We are a new type of pharmaceutical company dedicated to creating affordable, life-changing medicines for serious and life-limiting diseases and medical conditions
Pipeline
BiologX has an active pipeline of products in various stages of development
Therapeutic Area
Formulation
Research & Discovery
Regulatory & Review
Expected Commercialization
Diabetes
Short Acting
(RHI)
Type1, Type 2
IV, Pen, Pump
Rapid Acting
Glulisine
Type1, Type 2
IV, Pen, Pump
Intermediate Acting
(NPH)
Type1, Type 2
IV, Pen, Pump
Long Acting
Glargine
Type1, Type 2
IV, Pen, Pump
Combination
70/30
Type1, Type 2
IV, Pen, Pump
GLP - 1
Type1, Type 2
IV, Pen, Pump
Manufacturing
At BiologX, we build our products to the highest quality standards on state-of-the-art automated manufacturing lines because we know that when it comes to potentially life-saving products you expect the very best.
Development&Regulatory
Our team has decades of experience in both U.S. and global regulatory filings. BiologX’s development process includes several rigorous studies, which involve feedback from patients and other stakeholders. This sets us apart; the knowledge and insights gained from listening to our users becomes core part of our submissions. We conduct our clinical studies under the most stringent of regulatory requirements.
Commercialization
Our commercial team has over 50 years of experience bringing valuable therapies to patients. BiologX commercializes its products through two models:
1. Commercialize products ourselves in specific therapeutic areas. 2. License our products to commercial partners who have the resources and capabilities for our products to reach their potential.
